AU6357890A - Expression of alpha-macroglobulins - Google Patents

Expression of alpha-macroglobulins

Info

Publication number
AU6357890A
AU6357890A AU63578/90A AU6357890A AU6357890A AU 6357890 A AU6357890 A AU 6357890A AU 63578/90 A AU63578/90 A AU 63578/90A AU 6357890 A AU6357890 A AU 6357890A AU 6357890 A AU6357890 A AU 6357890A
Authority
AU
Australia
Prior art keywords
macroglobulins
alpha
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63578/90A
Inventor
Boel Esper
Sottrup-Jensen Lars
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK423589A external-priority patent/DK423589D0/en
Priority claimed from DK423689A external-priority patent/DK423689D0/en
Priority claimed from DK423789A external-priority patent/DK423789D0/en
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU6357890A publication Critical patent/AU6357890A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
AU63578/90A 1989-08-29 1990-08-29 Expression of alpha-macroglobulins Abandoned AU6357890A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DK4237/89 1989-08-29
DK423589A DK423589D0 (en) 1989-08-29 1989-08-29 EXPRESSION OF A HUMAN PLASMAGLYCOPROTEIN
DK423689A DK423689D0 (en) 1989-08-29 1989-08-29 USE OF A HUMAN PLASMAGLYCOPROTEIN
DK4235/89 1989-08-29
DK4236/89 1989-08-29
DK423789A DK423789D0 (en) 1989-08-29 1989-08-29 EXPRESSION AND USE OF A HUMAN PLASMAGLYCOPROTEIN

Publications (1)

Publication Number Publication Date
AU6357890A true AU6357890A (en) 1991-04-08

Family

ID=27221960

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63578/90A Abandoned AU6357890A (en) 1989-08-29 1990-08-29 Expression of alpha-macroglobulins

Country Status (4)

Country Link
EP (1) EP0489830A1 (en)
JP (1) JPH05500005A (en)
AU (1) AU6357890A (en)
WO (1) WO1991003557A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6472140B1 (en) 1997-09-05 2002-10-29 The General Hospital Corporation α-2- macroglobulin therapies and drug screening methods for Alzheimer's disease.
US6342350B1 (en) 1997-09-05 2002-01-29 The General Hospital Corporation Alpha-2-macroglobulin diagnostic test
EP1409725B1 (en) 2001-03-07 2014-05-07 Andre Schuh Diagnosis and treatment of blood disorders
US7700316B2 (en) 2001-03-07 2010-04-20 Andre Schuh CD109 nucleic acid molecules, polypeptides and methods of use
GB0224116D0 (en) * 2002-10-16 2002-11-27 Ares Trading Sa Proteins
WO2008024767A2 (en) * 2006-08-21 2008-02-28 Wisconsin Alumni Research Foundation Method and composition for treating a fibrotic disorder

Also Published As

Publication number Publication date
WO1991003557A1 (en) 1991-03-21
JPH05500005A (en) 1993-01-14
EP0489830A1 (en) 1992-06-17

Similar Documents

Publication Publication Date Title
AU5748990A (en) Venoscope
AU5874690A (en) Octreotide-pamoate
AU627080B2 (en) Sulphonylaminocarbonyltriazolinones
EP0432600A3 (en) Derivatives of 2-iminopyridine
AU623262B2 (en) Hydroxypropylamines
AU6673290A (en) Dipyridodiazepines
AU631622B2 (en) Snow-vehicle
AU623780B2 (en) Chromanderivate
AU613543B2 (en) Preparation of halofluorobenzenes
AU6660090A (en) Treatment of depression
AU4552389A (en) Preparation of n-acyl-aminomethylphosphonates
AU5336690A (en) Leg-guard
AU5782590A (en) Thioxotetrazolines
AU5572890A (en) Manufacture of containers
AU6627590A (en) Doll-container
AU6839190A (en) Triazolylsulfonamides
AU5400390A (en) Substituted 1-phenylnaphthalenes
AU6357890A (en) Expression of alpha-macroglobulins
AU6260690A (en) Further novel alkanophenones
AU5915590A (en) Certain glyoxyl-cyclohexendiones
AU6268590A (en) Aminophosphinates
YU53490A (en) Derivatives of tetrahydronaphtaline
AU4944090A (en) Cryoelectrosynthesis
AU6217090A (en) Substituted amino-pyridines
AU4958690A (en) Preparation of 2-halofluorobenzene